44th Annual Carrell Krusen Neuromuscular Symposium (RP2202A)
This symposium is a clinical education experience for members of multidisciplinary teams who care for patients with rare, complex neuromuscular diseases including hereditary muscular dystrophies, motor neuron diseases, neuroimmunologic neuropathies and rare genetic disorders of muscle and nerve. Case presentations will include physical diagnosis and discussion of management and new therapies by participating experts. All discussions involve active participation by attendees. The educational format for this activity includes didactic lectures with in depth Q&A, panel discussions, and PowerPoint Presentations. The content of the program is identified and developed through a Call for Abstracts process. The 2022 keynote speaker will present data from the latest clinical trials for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Click on the Register tab to save your spot!
|Registration Type||Before 2/17/22|
After 2/17/ 22
|Advanced Practice Providers (PA/NP)/Nurses||$0||$10|
|Other Healthcare Providers (OT/PT, SPL, Research Coordinators)||$0||$10|
Help shape the conference by CLICKING HERE TO SUBMIT AN ABSTRACT! The deadline for abstract submission is Wednesday, December 1, 2021!
We are proud to announce that the 2022 Keynote Speaker is
Eva Feldman, M.D., Ph.D.
Russell N. DeJong Professor of Neurology
Director, ALS Center of Excellence
University of Michigan
This program is specifically designed for Primary Care providers, Neurologists, NPs, PAs, and RNs that desire to gain advanced knowledge in diagnosis and management of patients with neuromuscular disease.
- Discuss the elements in formulating a diagnosis and management plan for rare genetic diseases such as Amyotrophic Lateral Sclerosis (ALS).
- Discuss recent advances in the genetic diagnosis of neuromuscular disorders, in research and clinical practice and the latest developments in treatment such as gene replacement therapy.
- Identify and apply current pharmacological and non-pharmacological treatments in motor neuron diseases including gene replacement therapy
- Identify considerations for effective care coordination of patients with neuromuscular disease
- Recognize the current and most effective clinical applications of testing in neuromuscular disorders (to include histopathology).
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas Southwestern Medical Center designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.